Shareholding disclosure

Saba Capital Management, L.P

Declared position

4.962%

Threshold

Crossed upwards

Timeline

Published

03.04.2026

Transaction

31.03.2026

Voting rights breakdown

Voting rights acquired4.962%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

ZA01-000000000RW53

Beneficial owner

Saba Capital Management, L.P

Declared address

Saba Capital Management, L.P., New York, US

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Saba Capital Management, L.P

BB Biotech AG03.04.2026ZA01-000000000RW53

Disclosure summary

Saba Capital Management, L.P disclosed a holding in BB Biotech AG on the acquisition side, published by SIX Exchange Regulation on 03.04.2026, at 4.962% of voting rights. Notice category: Single shareholder.

Disclosed position

4.962%

Voting rights acquired

Voting rights acquired4.962%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Saba Capital Management, L.P disclosed a holding in BB Biotech AG, published on 03.04.2026.

Publication date03.04.2026

Transaction date31.03.2026

Issuing companyBB Biotech AG

Beneficial ownerSaba Capital Management, L.P

Declared addressSaba Capital Management, L.P., New York, US

CategorySingle shareholder

Voting rights acquired4.962%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDZA01-000000000RW53

Source: SIX Exchange Regulation · Publication date: 03.04.2026

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open